Abstract
Limited data are available concerning the outcome of patients with atypical and malignant meningiomas. We therefore analyzed the outcome of seventeen patients with meningiomas (9 atypical; 8 malignant) at Thomas Jefferson University Hospital between 1973 and 1996. Strict adherence to the 1993 WHO criteria for the typing of CNS tumors was maintained.
The median potential follow-up period for all patients was 87 months. The age at diagnosis ranged from 22 to 72 (mean 51.8 years). There were 5 males and 12 females. The mean tumor diameter was 4.45 cm. Of the 16 cases where the extent of surgical resection was known, 4 were partial and 12 were complete resections. Six patients (35%) had dural or cortical invasion by tumor. Fifteen patients received postoperative megavoltage photon irradiation (mean 61 Gy). One of these fifteen pts. received an additional 20 Gy with Au-198 implantation and 1 received post-radiation chemotherapy for recurrent disease.
The overall survival rate for all patients at 5 and 10 years were 87% and 58% respectively. The 5- and 10-year survival rates for atypical meningiomas were 87% and 58%; for malignant meningiomas the survival rates were 60% and 60% respectively. Five patients (30%) have died. Three of these 5 patients initially received less than 54 Gy to the tumor bed and have died of recurrent disease. Local disease progression was documented in 11 patients (65%) after surgery and in 3 patients (18%) after radiation. There was an improvement in performance status in 3 (18%) paients with a decline and no change seen in 1 (6%) and 13 (77%) respectively after receiving radiation. There appeared to be no difference in survival in patients as a function of dural or cortical invasion.
Long term survival is possible for patients with atypical and malignant meningiomas treated with surgery and post-operative radiation. We are unable to distinguish a difference in outcome between these two pathological entities. Dural and cortical invasion were not associated with a decrease in survival. In addition, improved tumor control and survival may be associated with increased radiation dose.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Maier H, Ofner D, Hittmair A, Dictmar O, Kitz K, Budka H: Classic, atypical and anaplatic meningioma: three histopathological subtypes of clinical relevance. J Neurosurg 77: 616–623, 1992
Mirabell R, Lingood RM, de la Mont S: The role of radiation therapy in the treatment of subtotally resected benign meningiomas. J Neuro-oncol 13: 157–164, 1992
Glaholm J, Bloom HJ, Crow H: The role of radiotherapy in the management of intracranial meningiomas: The Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 18: 755–761, 1990
Taylor B, Mareus R, Friedman W, Ballinger W, Million R: The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 15: 299–304, 1988
Kleihues P, Burger BC, Scheithauer BA, Sobin LH: Histological typing of tumours of the central nervous system. In: World Health Organization International Classification of Tumours. Springer-Verlag, 1993, pp 33–37
Milosevic MF, Frost PJ, Laperriere NJ, Wong CS, Simpson WJ: Therapy for atypical or malignant intracranial meningioma. Int J Radiat Oncol Biol Phys 34: 817–822, 1996
Thomas H, Clarisse LD, Berry K: Malignant meningioma: clinical and pathological features. J Neurosurg 55: 929–934, 1981
Alvarez F, Roda JM, Blazquez MG: Malignant and atypical meningiomas: a reappraisal of clinical, histological, and computed tomographic features. Neurosurg 20: 688–694, 1987
Hoshino T, Nagashima T, Murovic JA, Wilson C, Davis R. Proliferative potential of human meningiomas of the brain. A cell kinetics study with Bromodeoxyuridine. Cancer 58: 1466–1472, 1986
Chamberlin MC: Adjuvant combined modality therapy for malignant meningiomas. J Neurosurg 84: 733–736, 1996
Goldsmith BJ, Wara WM, Wilsonn B, Larson DA: Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 80: 195–201, 1994
Barharo NM, Gutin PH, Wilson CB, Sheline GE, Boldrey EB, Wara WM: Radiation therapy in the treatment of partially resected meningiomas. Neurosurg 20: 525–528, 1987
de Monte F: Current management of meningiomas. Oncol 9: 83–101, 1995
Inoue H, Tamura M, Koizumi H, Nakamura M, Naganuma H, Ohye C: Clinical pathology of malignant meningiomas. Acta Neurochir 73: 179–191, 1984
Devita VT, Hellman S, Rosenberg SA (eds): Cancer, Principles and Practices of Oncology. J.B. Lippincott Co., 1993, pp 1712–1714
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Coke, C.C., Corn, B.W., Werner-Wasik, M. et al. Atypical and malignant meningiomas: an outcome report of seventeen cases. J Neurooncol 39, 65–70 (1998). https://doi.org/10.1023/A:1005981731739
Issue Date:
DOI: https://doi.org/10.1023/A:1005981731739